Common Contracts
2 similar Sub-License Agreement contracts
LIFE HEALTHCARE CONCLUDES AGREEMENT TO SUB-LICENSE “RM2” (Bombesin)Sub-License Agreement • June 27th, 2024
Shareholders and noteholders are advised that Life Healthcare, through its wholly owned subsidiary Life Molecular Imaging Limited (“LMI”), has entered into a contract with Lantheus Holdings, Inc. (“Lantheus”), to sub-license one of LMI’s early-stage novel radiotherapeutic and radio diagnostic products (“RM2”) (“the Agreement”).
LIFE HEALTHCARE CONCLUDES AGREEMENT TO SUB-LICENSE “RM2” (Bombesin)Sub-License Agreement • June 27th, 2024
Shareholders and noteholders are advised that Life Healthcare, through its wholly owned subsidiary Life Molecular Imaging Limited (“LMI”), has entered into a contract with Lantheus Holdings, Inc. (“Lantheus”), to sub-license one of LMI’s early-stage novel radiotherapeutic and radio diagnostic products (“RM2”) (“the Agreement”).
